Ally Bridge Group (Ny) LLC Natera, Inc. Transaction History

Ally Bridge Group (Ny) LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $8.13 Million - $24.5 Million	-268,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$100.17 - $126.36 $5.01 Million - $6.32 Million	50,000 Added 22.94%	268,000 $29.9 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $2.74 Million - $3.73 Million	30,000 Added 15.96%	218,000 $22.1 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $12.5 Million - $21 Million	188,000 New	188,000 $18.7 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.